The team behind Osso VR, the VR surgical training platform, said that their software has now been used by more than 1,000 surgeons over the past month worldwide.
This platform, which was created to provide a surgical environment similar to the original condition, and can be repeated by surgeons, to safely practice their expertise, is now used by more than 20 teaching hospitals, and eight well-known medical device companies in 11 countries.
They said that the leading hospitals using the 'Osso VR' Surgical Training Platform were Brown University, Vanderbilt University, Hospitals for Special Surgery, Marshall University, Newcastle Simulation Center, University of Hawaii, UCLA, Washington University, Wake Forest Baptiste Health, University of Kentucky, University of Utah, and University of New York.
In addition to offering risk-free practice sessions and performance analysis, this platform also helps bridge by allowing surgeons to practice and given instructions on how to use new equipment without having to make a physical trip to a conference or location-based training session. In addition, it can be done in a standalone virtual environment or in a shared mechanism with groups.
"This technology can drastically change the lives of our patients, and it is very important for us to maximize access to this platform. Our continued expansion is a sign of the global nature of this training gap and the scalability of Osso technology, "said Justin Barad, MD, CEO, and founder of Osso VR.
Furthermore, Justin Barad stressed, "Patients now want the most valuable treatment, which often involves new and innovative medical technology. Surgeons are eager to provide the best service for their patients, but may not have the tools that allow them to utilize these new techniques. Osso VR maximizes the performance of the surgical team, giving them the skills and objective belief that they can bring significant value to their patients using the best value devices. "
The company said its main focus was to increase access to direct training that improved outcomes for patients and "increases the adoption of high-value medical technology."